$6.51B
$411 Million
0.05% of portfolio
4,930
Q3 2025
Added 10.41%
$1.45B
$426 Million
0.05% of portfolio
5,515
Q3 2025
Reduced 6.53%
$283B
$407 Million
0.05% of portfolio
3,175
Q3 2025
Reduced 11.81%
$0
$435 Million
0.05% of portfolio
2,107
Q2 2025
New
Halozyme Therapeutics Inc
-
$445 Million
0.05% of portfolio
-
Q2 2025
Reduced 9.94%
$0
$444 Million
0.05% of portfolio
6,580
Q4 2024
Added 90.17%
$0
$420 Million
0.05% of portfolio
10,595
Q2 2025
New
-
$375 Million
0.05% of portfolio
-
Q3 2025
New
$0
$397 Million
0.05% of portfolio
5,239
Q2 2025
Added 55.28%
$3.63B
$447 Million
0.05% of portfolio
17,500
Q2 2025
Reduced 9.33%
$270B
$440 Million
0.05% of portfolio
2,769
Q3 2025
Reduced 13.52%
$4.81B
$421 Million
0.05% of portfolio
9,750
Q3 2025
Reduced 17.37%
$70.1B
$394 Million
0.05% of portfolio
2,312
Q3 2025
Reduced 19.61%
-
$389 Million
0.05% of portfolio
-
Q1 2025
New
$23.5B
$374 Million
0.05% of portfolio
638
Q3 2025
Added 16.42%
$1.92B
$452 Million
0.05% of portfolio
10,399
Q2 2024
Reduced 16.72%
$1.75B
$434 Million
0.05% of portfolio
8,320
Q3 2025
Reduced 2.15%
$3.77B
$425 Million
0.05% of portfolio
8,712
Q3 2025
Added 14.29%
$7.67B
$391 Million
0.05% of portfolio
31,300
Q2 2025
Added 10.21%
$4.63B
$394 Million
0.05% of portfolio
5,153
Q3 2025
Added 9.08%
$940M
$403 Million
0.05% of portfolio
19,800
Q3 2025
Added 3.94%
-
$376 Million
0.05% of portfolio
-
Q1 2025
Reduced 15.46%
$2.9B
$409 Million
0.05% of portfolio
4,561
Q3 2025
Added 30.31%
-
$451 Million
0.05% of portfolio
-
Q3 2025
New
$291B
$439 Million
0.05% of portfolio
921
Q3 2025
Reduced 15.04%
$44.3B
$397 Million
0.05% of portfolio
44,240
Q3 2025
Reduced 10.52%
$22B
$438 Million
0.05% of portfolio
8,040
Q3 2025
Reduced 62.18%
$2.32B
$444 Million
0.05% of portfolio
21,504
Q2 2025
Added 12.65%
$228B
$453 Million
0.05% of portfolio
3,383
Q3 2025
Reduced 2.54%
$6.49B
$417 Million
0.05% of portfolio
931
Q3 2025
Added 10.83%
-
$292 Million
0.04% of portfolio
-
Q4 2024
New
$9.3B
$310 Million
0.04% of portfolio
6,855
Q3 2025
Added 21.22%
-
$323 Million
0.04% of portfolio
-
Q2 2025
Reduced 31.45%
$9.31B
$360 Million
0.04% of portfolio
15,800
Q3 2025
Added 5.33%
-
$342 Million
0.04% of portfolio
-
Q3 2025
Reduced 12.17%
Mirum Pharmaceuticals Inc
-
$300 Million
0.04% of portfolio
-
Q3 2025
Reduced 32.8%
Alnylam Pharmaceuticals Inc
-
$368 Million
0.04% of portfolio
-
Q3 2025
Reduced 39.13%
-
$342 Million
0.04% of portfolio
-
Q3 2025
Added 39.11%
-
$309 Million
0.04% of portfolio
-
Q3 2025
New
$1.38B
$358 Million
0.04% of portfolio
23,476
Q2 2025
Reduced 1.79%
-
$299 Million
0.04% of portfolio
-
Q3 2024
New
$9.38B
$316 Million
0.04% of portfolio
10,000
Q3 2025
Reduced 11.5%
$52.1B
$294 Million
0.04% of portfolio
24,598
Q2 2025
Added 16.52%
$45.2B
$333 Million
0.04% of portfolio
5,570
Q3 2025
Added 14.37%
$1.57B
$308 Million
0.04% of portfolio
6,157
Q3 2025
Added 9.85%
-
$343 Million
0.04% of portfolio
-
Q3 2025
New
$2.98B
$361 Million
0.04% of portfolio
18,000
Q2 2025
Reduced 5.26%
$2.41B
$326 Million
0.04% of portfolio
25,000
Q2 2024
Reduced 16.67%
-
$305 Million
0.04% of portfolio
-
Q2 2025
New
$3.65B
$319 Million
0.04% of portfolio
8,574
Q3 2025
Reduced 1.22%